Slap Your Way to Larger Breasts

Please tweet and retweet Tweet

35 year old Bangkok, Thailand beautician Khemmika Na Songkhla also known as Khunying Tobnom claims to be able to enlarge your breasts without surgery—by slapping them. Her grandmother mocked her for wasting time rubbing her nipples with a miracle cream when she was in her early teens in hopes of sprouting big breasts. Her grandmother then advised her to rub them till they hurt and repeatedly push fat from her sides and abdomen towards her chest, and then douse the breasts with ice water. She claims that by following her grandmother's advice she boosted her breast size by 4inches and her confidence soared. Ms Khemmikka says that by using this non-surgical technique (squeezing, pinching and slapping fat and muscle on the upper chest, the sides of the torso, and the belly of clients with cream or gel for an hour over six 10-minute sessions for a total cost of $380) she has enlarged the breasts up to 4 inches in thousands of Thai women over the past 14 years without injections, chemicals or implants. After the treatment Khemmika instructs her customers in special exercise techniques and massage to keep their breasts in shape.

PIP Silicone Breast Implant Recall

Please tweet and retweet Tweet

The French company Poly Implant Prothese, or PIP manufactured breast implants and supplied a large portion of the European breast implant market. The company was based in the south of France and for awhile was the number 3 breast implant producer in the world. 80% of production was exported out of France. While having undisclosed financial problems it began to cut costs by using a cheaper industrial grade silicone in the implants rather than medical grade silicone. This cut manufacturing costs by up to euro 1 million ($1.3 million) a year. A lawyer for the company told authorities that the switch to cheaper silicone began in 1991, shortly after the company began production. These implants were also marketed under the name M-implant by the company Rofil Medical in the Netherlands and distributed in Germany by the company Rofil Medro. Affected Rofil implants are designated as IMGHC-TX, MX-IMGHC, and IMGHC-LS.